Novartis Venture Fund and Hikma Ventures have co-led a series A round for online prescription management platform Lemonaid Health, taking its total funding to near $20m.
US-based online healthcare platform Lemonaid Health has raised $11m in a series A round co-led by the corporate venturing units of pharmaceutical companies Novartis and Hikma Pharmaceuticals.
Novartis Venture Fund and Hikma Ventures were joined by venture capital firms Correlation Ventures and 415 Ventures, investment fund Adaptive Healthcare Fund, and VC firm and consulting boutique Vega Ventures.
Lemonaid has built an online platform that facilitates prescriptions for birth control pills and conditions such as acid reflux, influenza, hair loss and…